Pressure actuated valve with improved biasing member

Abstract
A valve for controlling material flow through a catheter, comprises a first flexible member including a first moveable element, wherein, when the first moveable element is in the open position, material may flow past the first flexible member through a first lumen of the catheter and, when the first moveable element is in the closed position, flow through the first lumen is prevented and a first biasing member coupled to the first flexible member for biasing the first moveable member toward the closed position.
Description
BACKGROUND INFORMATION

Many medical procedures require repeated and prolonged access to a patient's vascular system. For example, during dialysis treatment blood may be removed from the body for external filtering and purification, to make up for the inability of the patient's kidneys to carry out that function. In this process, the patient's venous blood is extracted, processed in a dialysis machine and returned to the patient. The dialysis machine purifies the blood by diffusing harmful compounds through membranes, and may add to the blood therapeutic agents, nutrients etc., as required before returning it to the patient's body. Typically the blood is extracted from a source vein (e.g., the vena cava) through a catheter sutured to the skin with a distal needle of the catheter penetrating the source vein.


It is impractical and dangerous to insert and remove the catheter for each dialysis session. Thus, the needle and catheter are generally implanted semi permanently with a distal portion of the assembly remaining within the patient in contact with the vascular system while a proximal portion of the catheter remains external to the patient's body. The proximal end is sealed after each dialysis session has been completed to prevent blood loss and infections. However, even small amounts of blood oozing into the proximal end of the catheter may be dangerous as thrombi can form therein due to coagulation which thrombi may then be introduced into the patient's vascular system when blood flows from the dialysis machine through the catheter in a later session.


A common method of sealing the catheter after a dialysis session is to shut the catheter with a simple clamp. This method is often unsatisfactory because the repeated application of the clamp may weaken the walls of the catheter due to the stress placed on the walls at a single point. In addition, the pinched area of the catheter may not be completely sealed allowing air to enter the catheter which may coagulate any blood present within the catheter. Alternatively, valves have been used at the opening of the catheter in an attempt to prevent leaking through the catheter when the dialysis machine is disconnected. However, the unreliability of conventional valves has rendered them unsatisfactory for extended use.


SUMMARY OF THE INVENTION

The present invention is directed to a valve for controlling material flow through a catheter, comprising a first flexible member including a first moveable element, wherein, when the first moveable element is in the open position, material may flow past the first flexible member through a first lumen of the catheter and, when the first moveable element is in the closed position, flow through the first lumen is prevented and a first biasing member coupled to the first flexible member for biasing the first moveable member toward the closed position.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a schematic diagram of a vascular access catheter;



FIG. 2 is a schematic drawing of a vascular access catheter inserted in a patient's vein;



FIG. 3 is a top elevation view of a valve device according to an exemplary embodiment of the present invention;



FIG. 4 is a top elevation view of a valve device according to another embodiment of the present invention;



FIG. 5 is a top elevation view of a valve device with double horizontal slits according to an embodiment of the present invention;



FIG. 6 is a top elevation view of a valve device with Y-configured slits according to an embodiment of the present invention; and



FIG. 7 is a top elevation view of a valve device with a curved slit according to an embodiment of the present invention.





DETAILED DESCRIPTION

Semi-permanently placed catheters may be useful for a variety of medical procedures which require repeated access to a patient's vascular system in addition to the dialysis treatments mentioned above. For example, chemotherapy infusions may be repeated several times a week for extended periods of time. For safety reasons, as well as to improve the comfort of the patient, injections of these therapeutic agents may be better carried out with an implantable, semi-permanent vascular access catheter. Many other conditions that require chronic venous supply of therapeutic agents, nutrients, blood products or other fluids to the patient may also benefit from implantable access catheters, to avoid repeated insertion of a needle into the patient's blood vessels. Thus, although the following description focuses on dialysis, those skilled in the art will understand that the invention may be used in conjunction with any of a wide variety of procedures which require long term implantation of catheters within the body.


Examples of such implantable catheters include those manufactured by Vaxcel™, such as the Chronic Dialysis Catheter and the Implantable Vascular Access System. These devices typically are inserted under the patient's skin, and have a distal end which includes a needle used to enter a blood vessel. The devices also have a proximal end extending outside the body for connection with an outside line. These semi-permanent catheters may be sutured to the patient's skin to maintain them in place while the patient goes about his or her normal occupations.



FIGS. 1 and 2 show an exemplary implantable catheter for kidney dialysis. Catheter 10 has a distal end 12 that is insertable under the skin and into the patient's vein, and which remains within the patient's body for the life of the catheter 10. For example, catheter 10 may remain implanted in the patient for two years. As shown more clearly in FIG. 2, distal end 12 fits within a vein 8 (e.g., the vena cava). During dialysis, blood from the patient is removed through a patient line such as catheter 10, and is purified by a dialysis machine (not shown) which is connected to hubs 18 and 20 of catheter 10 by a dialysis line. Catheter 10 in this example includes two lumens 22 and 24 which are used respectively to remove blood from and reintroduce blood to the vessel 8. Lumen 22 terminates at an inflow tip 14 formed at the distal end 12 of the catheter 10 while lumen 24 terminates at an outflow tip 16 formed at the distal end 12. Inflow tip 14 and outflow tip 16 are connected to corresponding inflow and outflow hubs 18, 20, which are accessible outside the body and which may be connected to external lines leading to and from the dialysis machine.


After the dialysis or other procedure has been completed, the catheter 10 is disconnected from the dialysis machine, and is left within the patient fluidly coupled to the patient's vascular system. When not connected to a dialysis machine, the catheter 10 is securely sealed to prevent fluids and gases from crossing into the proximal end of catheter 10 by preventing flow in and out of catheter 10 through hubs 18, 20. As would be understood by those skilled in the art, this sealing prevents the risks associated with infections and thrombi which might be experienced if air or other gas or liquid and/or pathogens were to pass into the catheter 10.


As indicated above, although conventional clamps or clips may be used to seal the catheter 10 between medical sessions, over time the wall of the catheter 10 may be damaged in the area to which the clamp or clip is applied. Sealing clamps or clips may also become dislodged during patient activities, increasing the risk of leaks, infections, etc. Placing a clamp on the catheter 10 also increases the bulk of the distal end of the catheter which is exposed outside the patient's body, and may adversely affect patient comfort.


Therefore, the catheter 10 includes one or more self sealing valves along each of the lumens 22, 24 to seal them when not being used during dialysis and other transfusion or infusion sessions. For example, hubs 18, 20 may be used to house one or more valves each of which is designed to seal the corresponding lumen 22, 24 under certain conditions, and to allow passage of fluids under other conditions. For example, in the case of dialysis treatment, the system of valves may seal the catheter 10 when it is not connected to an operating dialysis machine, and may allow both an outflow of non-purified blood and an inflow of purified blood to the patient when an operating dialysis machine is connected thereto.


Preferably, a valve system for use in such semi-permanent catheters should, when in the open position, allow a flow rate therethrough which is sufficient to allow the procedure to be completed in an acceptably short time. When in the closed position, the valve should completely seal the catheter. That is, if the valve requires excessive force to be opened, the flow rate through the catheter may be reduced to the point where the time required for the procedure is unacceptably extended. In addition, a valve system having moving parts of too great a bulk may also result in larger blockages within the catheter or the hub housing the valve thereby reducing the flow rate through the catheter. The mechanism that moves the valve into the open and closed positions may block the flow through the valve if it protrudes into the flow passage, and thus the size and bulk of the mechanism should preferably be minimized to avoid impeding flow through the open valve.


The portion of the valve that moves to the open position must also completely return to the closed position when the session is completed. For example, a pressure sensitive valve may be used, which opens in response to a pressure driving the flow through the catheter. In the case of a dialysis catheter, the valve or valves may open when a pressure generated by the dialysis machine exceeds a predetermined threshold to allow circulation and purification of the patient's blood. When the dialysis machine is turned off and the pressure in the dialysis line is reduced below the threshold, the valve is completely sealed to prevent further flow from and to the patient. Some pressure is also present in the patient line connecting the valve to the patient's vein as a result of the circulation in the patient's vascular system. Each of the valves must therefore be designed so that it will not respond to such pressure variations introduced by the vascular system and will not open unless a pressure above the threshold is generated externally, for example, by a dialysis machine.


The exemplary embodiments according to the present invention described herein obtain both a secure closure of a semi-permanent catheter implanted in a patient when the catheter is not in use and permit a flow passage that is easily opened to allow a sufficient flow rate when access to the vascular system is necessary.


In many applications, the pressure actuated valve system remains open for the entire length of a therapeutic session, which may last a significant amount of time. For example, in the case of a dialysis session, the valve system may remain open for up to four hours at a time, during sessions carried out up to three times a week. The exemplary embodiments of valves according to the present invention provide a seal to the catheter even after being maintained in the open position for prolonged periods of time.


Specific embodiments of the present invention will be described below with reference to the drawings. FIG. 3 shows a top plan view of an exemplary embodiment of a valve element 100 used to control the flow through a medical tube such as the catheter 10 of FIG. 1. For example, valve element 100 may be located in a flow passage within a valve housing formed in either or both of the hubs 18, 20, through which fluids flow to and from the distal end 12. As will be apparent to those skilled in the art, the valve housing may be placed at any other location along the length of catheter 10 and may be unitary with the catheter 10, or may be formed as a separate component. In addition, it will be apparent that a single valve housing with dual flow passages and one valve 100 within each of the flow passages may be provided instead of two separate valve housings for the hubs 18, 20, respectively, to independently control fluid flow in each direction. Inflow to the patient may take place via one of the dual flow passages of the single hub, and outflow from the patient via the other flow passage.


In the exemplary embodiment shown in FIG. 3, the valve element 100 is formed as a flexible disk 110 having dimensions appropriate to the size of the flow passage within the one of the hubs 18, 20 into which it is to be mounted. The flexible disk 110 may be formed of any sufficiently flexible material, such as a polymeric material. More specifically, the flexible disk 110 may be formed of silicone. The flexible disk 110 may also include a peripheral portion 116 adapted to be connected to an inner surface of the flow passage to seal perimeter of the flow passage around flexible disk 110. The valve element 100 includes a slit 112 which is extends through the entire thickness of the flexible disk 110. The slit 112 separates two movable elements 118 from one another to form an openable portion of the disk 110 which creates a flow passage therethrough when the movable elements 118 are placed in an open position separated from one another. For example, when the edges 120 of the movable elements 118 are moved out of the plane of the flexible disk 110, an opening through the flexible disk 110 is formed along the slit 112. In this exemplary embodiment, the movable elements 118 are formed as resilient flaps substantially constrained in all directions except along the slit 112. Accordingly, the elements 118 are substantially constricted and may only move along the edges 120 to form a relatively small opening.


In one exemplary embodiment the valve element 100 is used in conjunction with dialysis equipment, and movement of movable elements 118 to the open position is prompted by an actuating pressure of a fluid within dialysis lines 30, 32 which may be connected to the hubs 18, 20, respectively, to connect the catheter 10 to a dialysis machine. In particular, an actuating pressure is generated by pumps in the dialysis machine to move the patient's blood between the patient and the filtration equipment. Although the movable elements 118 are formed as flexible flaps, they are formed with a predetermined amount of resilience to allow them to remain in the closed position when not acted upon by the pressure in dialysis lines 30, 32. Specifically, the elements 118 are biased to remain in the closed position abutting one another along edges 120 at all times when they are not acted on by a pressure outside a range of approximately 22 to 44 mmHg. Specifically, as mentioned above, the elements 118 are formed so that the amount of resilience is sufficient to maintain them in the closed position without being forced open by fluid forces generated by natural circulation of the patient's blood. As would be understood by those skilled in the art, the amount of pressure required to open the movable elements 118 is a function of the resilience of the material forming those elements, the size and shape of the slit 112, and the size of the flow passage containing the valve element 100. The details of the geometry of the slit 112 and the movable elements 118 may be selected to obtain the desired characteristics of maximum flow in the open position, and to ensure that valve element 100 seals the flow passage when the pressure is removed.


A stiffening element 114 may be included in valve element 100, to better control the amount of force biasing the movable elements 118 to the closed position. In particular, coupling a stiffening element to an otherwise flexible disk 110 (or forming a stiffening element integrally therewith) provides a valve element 100 including movable elements 118 more resistant to plastic deformation during sessions lasting multiple hours in which the valve element 100 is kept open. An example of a suitable stiffening member is the addition of stiffening ring 114 to the flexible disk 110. The stiffening element 114 may, for example, be formed of a wire embedded within the valve element 100. Of course, those skilled in the art will understand that the stiffening element 114 may be formed of metal, plastic or any substantially rigid material.


In one exemplary embodiment, the stiffening ring 114 may be embedded within the material of the disk 110, to minimize the bulk of the combination. In different embodiments, stiffening elements may be bonded to one or both sides of the valve element 100, depending on the requirements of the use of the valve element 100. The shape of the stiffening elements used in the valve element 100 may also be modified, depending on the desired characteristics of the force urging the movable elements 118 to the closed position. Alternatively, the stiffening elements may be integrally formed with the disk 110.


As indicated above, the maximum flow that can pass through valve element 100 and the ability to close fully when the actuating pressure is removed are important design parameters for the pressure actuated valves described herein. According to embodiments of the invention, these design parameters may be controlled by properly shaping and sizing the slit or slits 112. Selection of the dimensions of the slit 112 results in movable elements 118 having a desired shape and being constrained along selected edges. In the exemplary embodiment shown in FIG. 3, a linear slit having a width d of approximately 0.002 inches and a length of approximately 0.150 to 0.280 inches is provided in the center of an oval flexible disk 110 extending along a major axis of the disk. The flexible disk 110 could have a thickness of approximately 0.015 to 0.030 inches and could be manufactured from silicone, as a result its surface resistivity rating would be approximately 35 to 70 A. The movable elements 118 used in this configuration are flaps that form an opening by deflecting away from the plane of the disk 110 due to their flexibility, since they are constrained along all sides except along the slit 112. This configuration provides satisfactory performance in a dialysis catheter application, with the catheter having conventional dimensions and providing conventional flow rates. For example, the pressure to which the valve may be subjected during dialysis may be in the range of 200 to 285 mmHg while the pressures applied to the valve by the patient's vascular system are expected to remain below 22 mmHg. Thus, the valve system will preferably be designed to remain sealed when not subjected to a pressure of at least 44 mmHg and, when subjected to the a pressure above that threshold should preferably allow a flow rate of at least 300 ml/min and more preferably at least 350 ml/min without substantially failing to meet these criteria during a life span of one or more years while being subjected to 3 or more uses of up to 4 hours each per week.


The performance characteristics of the valve element 100 can be further tuned by selecting an appropriate length l of the slit 112. By altering this length l, both the maximum flow rate and the opening/closing performance of the valve element 100 will be changed. For example, increasing the length of the slit 112, other parameters being the same, increases a maximum size of the opening through the flexible disk 110, and makes it easier to displace the movable elements 118 to the open position as they are unconstrained along longer edges 120. For the same reason, the movable elements 118 are subjected to a reduced force biasing them toward the closed position when the actuating pressure is removed. Both the width d and the length l of the slit 112 are selected as a tradeoff between ease/size of the opening and the biasing force closing the valve element 100 after use.


A different exemplary configuration of slits to define the movable elements is shown in FIG. 4. In this embodiment, a flexible disk 210 is provided with slits 212, 214 in a substantially H-shaped configuration that define movable elements 218. The slit 212 is a substantially linear slit aligned with a major dimension of the disk 210, and the slits 214 extend substantially perpendicular to slit 212, disposed near terminating points thereof. This configuration of slits permits the movable elements 218 to more easily move to the open configuration, since each movable element 218 is unconstrained along both the slit 212 and the slits 214. The pressure generated by an external pump, such as a dialysis pump, thus can more easily force the movable elements 218 to the open position. The two additional unconstrained sides of the movable elements 218 also form a larger open area of flexible disk 210, so that a greater flow rate can pass through the valve element 200.


Additional resilient elements may also be used in the exemplary embodiment shown in FIG. 4 to achieve desired closing characteristics of the valve element 200. For example, a pair of resilient elements 220 may be disposed substantially parallel to the slit 212 on either side thereof. The resilient elements 220 control the deflection and provide a force biasing the movable elements 218 toward the closed position along the axis of the slit 212. Those skilled in the art will understand that additional resilient elements 222 may be used to increase the biasing force and/or to control the deflection of the movable elements 218 along an axis parallel to the slits 214. This exemplary combination of H-configured slits and corresponding H-configured resilient elements results in a high flow, easily opened pressure actuated valve element 200, which is able to completely return to the closed position once the actuating pressure is removed. This configuration also resists plastic deformation that may occur when valve elements are kept in the open position for extended periods of time, and which may prevent the valve from fully closing due to retaining a “memory” of the open position.


Another exemplary embodiment according to the present invention is depicted in FIG. 5. In this embodiment, a double horizontal slit is used to define the movable elements of a valve element 250. More specifically, a pair of substantially parallel slits 262 extend through the flexible disk 260, substantially along a major dimension thereof. In the case of a substantially elliptical flexible disk 260, as shown, the slits 262 are substantially parallel to a major axis of the ellipse. A movable element 264 is thus defined substantially at the center of the flexible disk 260, and is constrained only at ends 265 thereof near termination points of the slits 262.


The greater unconstrained length of the sides of the movable element 264 along the slits 262, enables a large flow area to open as a result of an actuating pressure. For the same reason, a relatively low actuating pressure is needed to open the movable element 264. To ensure a complete closing of the valve element 250 when the actuating pressure is removed, for example, resilient elements may be added around the slits 262 to further bias the movable element 264 to the closed position. In the exemplary embodiment shown in FIG. 5, resilient elements 266, 268, which may comprise, for example, wires embedded within the valve element 250, are disposed in a substantially rectangular configuration surrounding the slits 262. In this configuration the resilient elements 266, 268 control the deflection of the movable element 264 in directions substantially parallel and perpendicular to the slit orientation and provide a biasing force that closes the movable element 264 when the actuating pressure is removed. The resilient elements 266, 268 may form a complete rectangle, or may be separated at the vertices.



FIG. 6 shows yet another embodiment of the pressure actuated valve according to the present invention. In this exemplary embodiment, a linear slit is combined with a pair of Y-configured slits to provide a larger flow area when a valve element 300 is placed in the open position by an actuating pressure thereagainst. As shown in the drawing, the valve element 300 is formed as a flexible disk 310 which, in this example, has a substantially elliptical shape. It will be apparent to those skilled in the art that different shapes of the flexible disk 310 may be used, depending on the shape and dimensions of the housing within which the valve element 300 is to be placed. A substantially linear slit 312 is formed in the flexible disk 310, for example along a major dimension thereof, and is complemented by two pairs of slits 314. A first pair of the slits 314 is disposed at a first end of the slit 312 with a second pair of slits 314 being formed at the second end of the slit 312. The slits 314 are formed at an angle with the slit 312, so that, at each end of the slit 312, a substantially Y-shaped configuration of slits is formed.


In the exemplary embodiment shown, the slits 312 and 314 do not touch one another so that the movable elements 320 are continuous with portions 322 of the flexible disk 320. In different embodiments, the slits 312 and 314 may intersect with one another, breaking the flexible disk 320 into additional distinct moving elements. In the exemplary embodiment shown, the movable elements 320 are unconstrained along the slits 312, 314, but are constrained in the region between the slits by being continuous with the portions 322 of the flexible disk 320. The addition of the Y-configured slits permits the movable elements 320 to open to a greater extent under an equivalent actuating pressure, while retaining a biasing force sufficient to completely close the opening when the actuating pressure is removed. To further bias the movable elements 320 toward the closed position, resilient elements 316, 318 may be added. As discussed in the context of previous embodiments, the resilient elements 316, 318 may be disposed in a substantially rectangular pattern around the slits 312, 314 to control the deflection and closure of the movable elements 320 in two directions substantially perpendicular to one another. The resilient elements 316, 318 may form a completely rectangular enclosure as shown in FIG. 6, or may have open vertices, as shown in previous embodiments. As would be understood by those skilled in the art, the relative size and orientation of the slits 312, 314 may be selected to give desired flow and closing properties, for a given flexible disk 320.


A different exemplary embodiment according to the present invention is depicted in FIG. 7. In this example, a valve device 350 comprises a flexible disk 360 having a slit 362 formed therein. The slit 362 is not formed as a linear slit, but instead is curved about a principal axis of the flexible disk 360. In the example shown in FIG. 7, the slit 362 follows a substantially sinusoidal path. However other curved paths may be used with similar effect. The slit 362 defines two movable elements 364, 366 which are complementary to each other along the slit 362. A benefit of this configuration is that for a given length l of the slit 362, a larger opening area of the valve device 350 is obtained as compared to linear slit designs. Since the unconstrained edges of the movable elements 364, 366 are longer due to their curved shape of the slit 362, a given actuating pressure displaces a larger portion of the movable elements 364, 366 to the open position. Thus, this design allows a larger flow area through the valve device 350.


As was the case in other the exemplary embodiments of the invention, the resilience of the movable elements 364, 366 is controlled to ensure that the valve element 350 fully closes once the actuating pressure is removed—even after remaining open for extended periods of time (i.e., to ensure that the valve is not subject to “memory” effects). Accordingly, the resilience of the material forming the movable elements 364, 366 is preferably selected and additional resilient elements are incorporated into the flexible disk 360, as described above with respect to other embodiments, based on the conditions to which the valve element 350 is to be subjected to ensure that such plastic deformation does not result in degraded performance over time.


The present invention has been described with reference to specific exemplary embodiments. Those skilled in the art will understand that changes may be made in details, particularly in matters of shape, size, material and arrangement of parts. For example, different flexible disks may be used to form the pressure sensitive valve, and may have different dimensions than those shown. Accordingly, various modifications and changes may be made to the embodiments without departing from the broadest scope of the invention as set forth in the claims that follow. The specifications and drawings are, therefore, to be regarded in an illustrative rather than a restrictive sense.

Claims
  • 1. A valve for controlling material flow through a catheter, comprising: a disk-shaped first flexible member including a plurality of slits, each of the slits being formed by respective first and second flaps, the first and second flaps moving, when subjected to a fluid pressure of at least a predetermined threshold level, to an open position so that material may flow past the first flexible member through a first lumen of the catheter, the first and second flaps remaining closed when a fluid pressure exerted there against is less than the threshold level to prevent flow through the first lumen, the first flexible member comprising a first material, wherein a length of at least one of the slits is approximately 0.15 to 0.28 inches and wherein at least one of the slits permits a flow rate there through of at least 300 ml/min when opened; anda first biasing member coupled to a surface of the first flexible member for biasing the first and second flaps of the plurality of slits toward the closed position, the first biasing member comprising a second material that is different from the first material.
  • 2. The valve according to claim 1, wherein the first flexible member is formed as a first sheet of polymeric material.
  • 3. The valve according to claim 1, wherein at least one of the slits has a width of approximately 0.002 inches.
  • 4. The valve according to claim 1, wherein a thickness of the first flexible member is approximately 0.015 to 0.030 inches.
  • 5. The valve according to claim 1, wherein the first flexible member has a surface resistivity of 35 to 75 A.
  • 6. The valve according to claim 1, wherein the slits remains closed when subjected to a pressure less than 44 mmHg.
  • 7. The valve according to claim 1, wherein at least one of the slits permits a flow rate there through of at least 350 ml/min when opened.
  • 8. The valve according to claim 1, wherein at least one of the slits is substantially linear.
  • 9. The valve according to claim 1, wherein the first biasing member extends around the plurality of slits.
  • 10. The valve according to claim 1, wherein the first biasing member is substantially rectangular.
  • 11. The valve according to claim 1, wherein the first biasing member is formed of a wire.
  • 12. The valve according to claim 1, wherein the first flexible member is formed substantially as a disc, and wherein at least one of the slits extends substantially parallel to a major axis of the disc.
  • 13. The valve according to claim 1, wherein at least two of the slits are parallel to each other.
  • 14. The valve according to claim 1, wherein the first flexible member is formed as a silicone disc.
  • 15. The valve according to claim 1, wherein at least two of the slits are perpendicular to each other.
  • 16. The valve according to claim 1, wherein at least two of the slits are angled with respect to an end of a third one of the slits according to a Y configuration.
  • 17. A valve housing for a catheter, comprising: a first end permanently coupled to a patient line a distal end of which is to be implanted within a patient's body and a second end connectable to an external line;a housing flow passage fluidly coupled to a flow passage of the patient line and selectively coupleable to a flow passage of the external line;a disk shaped valve mounted within the housing flow passage to selectively restrict flow of materials there through, the valve formed of a flexible sheet comprising a first material and including:a plurality of slits, each of the slits formed by respective first and second flaps separated from one another, the first and second flaps opening when a fluid pressure applied to the valve is at least a threshold pressure and remaining closed when the fluid pressure applied thereto is less than the threshold pressure, wherein a length of at least one of the slits is approximately 0.15 to 0.28 inches and wherein at least one of the slits permits a flow rate there through of at least 300 ml/min when opened; anda first biasing member coupled to a surface of the valve and biasing the first and second flaps of the plurality of slits toward the closed position, the first biasing member comprising a second material that is different from that first material.
  • 18. The valve housing according to claim 17, wherein the first slit has a width of approximately 0.002 inches.
  • 19. The valve housing according to claim 17, wherein the first biasing member is a wire.
  • 20. The valve housing according to claim 17, wherein the first biasing member is formed of at least one length of wire.
  • 21. The valve housing according to claim 20, wherein the at least one length of wire extends around the plurality of slits.
PRIORITY CLAIM

This application is a Continuation application of U.S. patent application Ser. No. 10/608,660 filed on Jun. 27, 2003 entitled “Pressure Actuated Valve with Improved Biasing Member”. The entire disclosure of this prior application is considered as being part of the disclosure of the accompanying application and hereby expressly incorporated by reference herein.

US Referenced Citations (163)
Number Name Date Kind
2720881 Weaver et al. Oct 1955 A
2755060 Raymond Jul 1956 A
3113586 Edmark Dec 1963 A
3159175 MacMillan Dec 1964 A
3159176 Russell et al. Dec 1964 A
3477438 Allen et al. Nov 1969 A
3514438 Nelsen et al. May 1970 A
3525357 Koreski Aug 1970 A
3621557 Cushman et al. Nov 1971 A
3669323 Harker et al. Jun 1972 A
3673612 Merrill et al. Jul 1972 A
3674183 Venable et al. Jul 1972 A
3710942 Rosenberg Jan 1973 A
3788327 Donowitz et al. Jan 1974 A
3811466 Ohringer May 1974 A
3955594 Snow May 1976 A
4072146 Howes Feb 1978 A
4142525 Binard et al. Mar 1979 A
4143853 Abramson Mar 1979 A
4244379 Smith Jan 1981 A
4387879 Tauschinski Jun 1983 A
4405316 Mittleman Sep 1983 A
4434810 Atkinson Mar 1984 A
4447237 Frisch et al. May 1984 A
4468224 Enzmann et al. Aug 1984 A
4502502 Krug Mar 1985 A
4524805 Hoffman Jun 1985 A
4543087 Sommercorn et al. Sep 1985 A
4552553 Schulte et al. Nov 1985 A
4610665 Matsumoto et al. Sep 1986 A
4616768 Flier Oct 1986 A
4646945 Steiner et al. Mar 1987 A
4673393 Suzuki et al. Jun 1987 A
4681572 Tokarz et al. Jul 1987 A
4692146 Hilger Sep 1987 A
4722725 Sawyer et al. Feb 1988 A
4790832 Lopez Dec 1988 A
4798594 Hillstead Jan 1989 A
4801297 Mueller Jan 1989 A
4908028 Colon et al. Mar 1990 A
4944726 Hilal et al. Jul 1990 A
4946448 Richmond Aug 1990 A
4960412 Fink Oct 1990 A
5000745 Guest et al. Mar 1991 A
5009391 Steigerwald Apr 1991 A
5030210 Alchas et al. Jul 1991 A
5084015 Moriuchi Jan 1992 A
5098405 Peterson et al. Mar 1992 A
5125893 Dryden Jun 1992 A
5147332 Moorehead Sep 1992 A
5149327 Oshiyama Sep 1992 A
5167638 Felix et al. Dec 1992 A
5169393 Moorehead et al. Dec 1992 A
5176652 Littrell Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5201722 Moorehead et al. Apr 1993 A
5205834 Moorehead et al. Apr 1993 A
5249598 Schmidt Oct 1993 A
5253765 Moorehead et al. Oct 1993 A
5324274 Martin Jun 1994 A
5330424 Palmer et al. Jul 1994 A
5336203 Goldhardt et al. Aug 1994 A
5360407 Leonard et al. Nov 1994 A
5370624 Edwards et al. Dec 1994 A
5396925 Poli et al. Mar 1995 A
5399168 Wadsworth et al. Mar 1995 A
5401255 Sutherland et al. Mar 1995 A
D357735 McPhee Apr 1995 S
5405340 Fageol et al. Apr 1995 A
5411491 Goldhardt et al. May 1995 A
5453097 Paradis Sep 1995 A
5454784 Atkinson et al. Oct 1995 A
5469805 Gibbs et al. Nov 1995 A
5470305 Arnett et al. Nov 1995 A
5484420 Russo Jan 1996 A
5542923 Ensminger et al. Aug 1996 A
5554136 Luther Sep 1996 A
5562618 Cai et al. Oct 1996 A
5571093 Cruz et al. Nov 1996 A
5575769 Vaillancourt et al. Nov 1996 A
5624395 Mikhail et al. Apr 1997 A
5637099 Durdin et al. Jun 1997 A
5667500 Palmer et al. Sep 1997 A
5707357 Mikhail et al. Jan 1998 A
5743873 Cai et al. Apr 1998 A
5743884 Hasson et al. Apr 1998 A
5743894 Swisher Apr 1998 A
5752938 Flatland et al. May 1998 A
5803078 Brauner Sep 1998 A
5807349 Person et al. Sep 1998 A
5810789 Powers et al. Sep 1998 A
5843044 Moorehead Dec 1998 A
5853397 Shemesh et al. Dec 1998 A
5865308 Qin et al. Feb 1999 A
5944698 Fischer et al. Aug 1999 A
5984902 Moorehead Nov 1999 A
5989233 Yoon Nov 1999 A
6033393 Balbierz et al. Mar 2000 A
6045734 Luther et al. Apr 2000 A
6050934 Mikhail et al. Apr 2000 A
6056717 Finch et al. May 2000 A
6062244 Arkans May 2000 A
6092551 Bennett Jul 2000 A
6120483 Davey et al. Sep 2000 A
6152909 Jones et al. Nov 2000 A
6210366 Sanfilippo Apr 2001 B1
6227200 Crump et al. May 2001 B1
6270489 Wise et al. Aug 2001 B1
6306124 Jones et al. Oct 2001 B1
6364861 Feith et al. Apr 2002 B1
6364867 Wise et al. Apr 2002 B2
6375637 Campbell et al. Apr 2002 B1
6436077 Davey et al. Aug 2002 B1
6442415 Bis et al. Aug 2002 B1
6446671 Armenia et al. Sep 2002 B2
6508791 Guerrero Jan 2003 B1
6551270 Bimbo et al. Apr 2003 B1
6610031 Chin Aug 2003 B1
6726063 Stull et al. Apr 2004 B2
6786884 DeCant et al. Sep 2004 B1
6874999 Dai et al. Apr 2005 B2
6953450 Baldwin et al. Oct 2005 B2
6994314 Garnier et al. Feb 2006 B2
7081106 Guo et al. Jul 2006 B1
7252652 Moorehead et al. Aug 2007 B2
7291133 Kindler et al. Nov 2007 B1
7316655 Garibotto et al. Jan 2008 B2
7435236 Weaver et al. Oct 2008 B2
7601141 Dikeman et al. Oct 2009 B2
7637893 Christensen et al. Dec 2009 B2
7758541 Wallace et al. Jul 2010 B2
20010023333 Wisse et al. Sep 2001 A1
20010037079 Burbank et al. Nov 2001 A1
20020010425 Guo et al. Jan 2002 A1
20020016584 Wise et al. Feb 2002 A1
20020121530 Socier Sep 2002 A1
20020165492 Davey et al. Nov 2002 A1
20020193752 Lynn Dec 2002 A1
20030122095 Wilson et al. Jul 2003 A1
20040034324 Seese et al. Feb 2004 A1
20040064128 Raijman et al. Apr 2004 A1
20040102738 Dikeman May 2004 A1
20040108479 Garnier et al. Jun 2004 A1
20040186444 Daly et al. Sep 2004 A1
20040193119 Canaud et al. Sep 2004 A1
20040210194 Bonnette et al. Oct 2004 A1
20040267185 Weaver et al. Dec 2004 A1
20050010176 Dikeman et al. Jan 2005 A1
20050027261 Weaver et al. Feb 2005 A1
20050043703 Nordgren Feb 2005 A1
20050049555 Moorehead et al. Mar 2005 A1
20050149116 Edwards et al. Jul 2005 A1
20050171490 Weaver et al. Aug 2005 A1
20050171510 DiCarlo et al. Aug 2005 A1
20050283122 Nordgren Dec 2005 A1
20060129092 Hanlon et al. Jun 2006 A1
20060135949 Rome et al. Jun 2006 A1
20060149211 Simpson et al. Jul 2006 A1
20070161940 Blanchard et al. Jul 2007 A1
20070161970 Moorehead et al. Jul 2007 A1
20070276313 Moorehead et al. Nov 2007 A1
20080108956 Lynn et al. May 2008 A1
20090292252 Lareau et al. Nov 2009 A1
Foreign Referenced Citations (30)
Number Date Country
20208420 Oct 2002 DE
0128625 Dec 1984 EP
198962 Oct 1986 EP
0337617 Oct 1989 EP
0864336 Sep 1998 EP
0930082 Jul 1999 EP
1016431 Jul 2000 EP
2508008 Dec 1982 FR
2718969 Oct 1995 FR
966137 Aug 1964 GB
2102398 Feb 1983 GB
59133877 Aug 1984 JP
06121499 Apr 1994 JP
9038197 Feb 1997 JP
WO-8902764 Apr 1989 WO
WO-9206732 Apr 1992 WO
WO-9516480 Jun 1995 WO
WO-9617190 Jun 1996 WO
WO 9623158 Aug 1996 WO
WO-9641649 Dec 1996 WO
WO-9723255 Jul 1997 WO
WO-9726931 Jul 1997 WO
WO-9822178 May 1998 WO
WO-9942166 Aug 1999 WO
WO-0006230 Feb 2000 WO
WO-0044419 Aug 2000 WO
WO-0174434 Oct 2001 WO
WO-03084832 Oct 2003 WO
WO-2005023355 Mar 2005 WO
WO-2008089985 Jul 2008 WO
Non-Patent Literature Citations (20)
Entry
elastomer. (2003). In The Macmillan Encyclopedia. Basingstoke, Hampshire: Macmillan Publishers Ltd. Retrieved Feb. 23, 2009, from http://www.credoreference.com/entry/3298087/.
Asch, “Venous access: options, approaches and issues,” Can Assoc. Radiol J., vol. 52, No. 3 pp. 153-164 (2001).
Herts et al., “Power injection of contrast media using central venous catheters: feasibility, safety, and efficacy,” AJR Am. J. Roentgenol., vol. 176, No. 2, pp. 447-453 (2001).
Roth et al., “Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters,” Cathet. Cardiovasc. Diagn., vol. 22, No. 4, pp. 290-294 (1991).
Carlson et al., “Safety considerations in the power injection of contrast media via central venous catheters during computered tomogrphic examinations,” Invest. Radiol., vol. 27, No. 5, p. 337-340 (1992).
Kaste et al., “Safe use of powr injectors with central and peripheral venous access devices for pediatrict CT,” Pediatr. Radiol., vol. 26, No. 8, pp. 449-501 (1996).
Herts et al., “Power injection of intravenous contrast material through central venous catheters for CT: in vitro evaluation,” Radiology, vol. 200, No. 3, pp. 731-735 (1996).
Rivitz et al., “Power injection of peripherally inserted central catheters,” J. Vasc. Interv. Radiol., vol. 8, No. 5, pp. 857-863 (1997).
Rogalla et al., Safe and easy power injection of contrast material through a central line, Eur. Radiol., vol. 8, No. 1, pp. 148-149 (1998).
Williamson et al., “Assessing the adequacy of peripherally inserted central catheters for power injection of intravenous contrast agents for CT,” J. Comput. Assist. Tomogr., vol. 25, No. 6, pp. 932-937 (2001).
Chahous et al., “Randomized comparison of coronary angiography using 4F catheters: 4F manual versus ‘Acisted’ power injection technique,” Catheter Cardiovasc. Interv., vol. 53, No. 2, pp. 221-224 (2001).
Walsh et al., “Effect of contrast agent viscosity and injection flow velocity on bolus injection pressures for peripheral venous injection in first-pass myocardial perfusion studies,” Technol. Health Care, vol. 10, No. 1, pp. 57-63 (2002).
Saito et al., “Diagnostic brachial coronary arteriography using a power-assisted injector and 4 French catheters with new shamps,” J. Invasive Cardiol., vol. 9, No. 7, pp. 461-468 (1997).
Examination Report mailed Apr. 7, 2006 for European Patent Application No. 04751644.8 (5 pages).
Examination Report mailed Apr. 6, 2010 for European Patent Application No. 04751644.8 (3 pages).
English Translation of Office Action mailed Aug. 18, 2009 for Japanese Patent Application No. 2006-517107 (3 pages).
English Translation of Office Action mailed Mar. 29, 2010 for Japanese Patent Application No. 2006-517107 (2 pages).
English Translation of Office Action mailed Jan. 28, 2011 for Japanese Patent Application No. 2006-517107 (3 pages).
International Search Report and Written Opinion mailed Nov. 5, 2004 for International Application No. PCT/US2004/014344 (9 pages).
International Preliminary Report on Patentability mailed Jan. 3, 2006 for International Application No. PCT/US2004/014344 (7 pages).
Related Publications (1)
Number Date Country
20090043261 A1 Feb 2009 US
Continuations (1)
Number Date Country
Parent 10608660 Jun 2003 US
Child 12250920 US